Details
Title
Author Correction: Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique
Author
Sánchez, Lina 1 ; Vidal, Marta 2 ; Jairoce, Chenjerai 3 ; Aguilar, Ruth 2 ; Ubillos, Itziar 2 ; Cuamba, Inocencia 4 ; Nhabomba, Augusto J. 4 ; Williams, Nana Aba 2 ; Díez-Padrisa, Núria 2 ; Cavanagh, David 5 ; Angov, Evelina 6 ; Coppel, Ross L. 7 ; Gaur, Deepak 8 ; Beeson, James G. 9 ; Dutta, Sheetij 6 ; Aide, Pedro 4
; Campo, Joseph J. 3 ; Moncunill, Gemma 3 ; Dobaño, Carlota 3
1 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413); UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757)
2 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413)
3 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413); Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique (GRID:grid.452366.0) (ISNI:0000 0000 9638 9567)
4 Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique (GRID:grid.452366.0) (ISNI:0000 0000 9638 9567)
5 University of Edinburgh, King’s Buildings, Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
6 Walter Reed Army Institute of Research (WRAIR), U.S. Military Malaria Vaccine Program, Silver Spring, USA (GRID:grid.507680.c) (ISNI:0000 0001 2230 3166)
7 Monash University, Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
8 Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India (GRID:grid.425195.e) (ISNI:0000 0004 0498 7682); Jawaharlal Nehru University, Laboratory of Malaria and Vaccine Research, School of Biotechnology, New Delhi, India (GRID:grid.10706.30) (ISNI:0000 0004 0498 924X)
9 Burnet Institute, Melbourne, Australia (GRID:grid.1056.2) (ISNI:0000 0001 2224 8486)
; Campo, Joseph J. 3 ; Moncunill, Gemma 3 ; Dobaño, Carlota 3
1 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413); UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757)
2 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413)
3 ISGlobal, Hospital Clínic—Universitat de Barcelona, Barcelona, Spain (GRID:grid.410458.c) (ISNI:0000 0000 9635 9413); Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique (GRID:grid.452366.0) (ISNI:0000 0000 9638 9567)
4 Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique (GRID:grid.452366.0) (ISNI:0000 0000 9638 9567)
5 University of Edinburgh, King’s Buildings, Institute of Immunology & Infection Research and Centre for Immunity, Infection & Evolution, Ashworth Laboratories, School of Biological Sciences, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)
6 Walter Reed Army Institute of Research (WRAIR), U.S. Military Malaria Vaccine Program, Silver Spring, USA (GRID:grid.507680.c) (ISNI:0000 0001 2230 3166)
7 Monash University, Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Melbourne, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
8 Malaria Group, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi, India (GRID:grid.425195.e) (ISNI:0000 0004 0498 7682); Jawaharlal Nehru University, Laboratory of Malaria and Vaccine Research, School of Biotechnology, New Delhi, India (GRID:grid.10706.30) (ISNI:0000 0004 0498 924X)
9 Burnet Institute, Melbourne, Australia (GRID:grid.1056.2) (ISNI:0000 0001 2224 8486)
Publication year
2022
Publication date
2022
e-ISSN
20590105
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2699838445
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.